Skip to content.

Bio-IT World

On-Demand: White Papers
Visit our white paper library often
to understand more about key
technology issues in bio-IT today
Bio-IT World
Conference & Expo

April 30 - May 2, 2007
Register by March. 16th
& SAVE up to $200!
Personal tools
March 14, 2007 | Home > Health-IT > Business+Strategy >

Business+Strategy :: News & Opinion

Schering-Plough Tries to Deal Its Way to Top
Mar 13 | The Wall Street Journal | After spending the past four years patiently nursing midsize drug maker Schering-Plough Corp. back to health, veteran pharmaceutical-industry executive Fred Hassan resumed doing what he loves most: making deals. more
Schering-Plough to Buy Akzo's Drug-Making Division for $14.4B
Mar 12 | Bloomberg.com | Schering-Plough Corp. agreed to buy Akzo Nobel NV's drug-making division Organon for $14.4 billion in cash to gain the world's third-largest maker of birth-control pills and a stable of experimental medicines. more
Biotech Interests Give FDA an Earful Over Regulations
Mar 12 | San Jose Business Journal | Companies in Silicon Valley and around the country that are pioneering personalized medicine are anxiously awaiting new regulations from the FDA that could change the way they do business. more
When Clinical Trial Results Just Say 'No'
Mar 12 | The San Francisco Chronicle | Biotech companies often are able to bounce back from seeming disaster, thanks to deep reserves and partnerships. more
Researchers Say FDA Increases Public Risks By Delaying Safety Data Release
Mar 09 | The Boston Globe | Heart problems that pushed the painkillers Bextra and Vioxx off the market could have come to light earlier had federal regulators given outside researchers speedier access to raw safety data, according to a commentary written by Boston researchers. more
Refining Data Mining
Mar 08 | The RPM Report The FDA and pharmas are taking control of a powerful new tool for drug safety analysis. But there are concerns. more
Analysis: New Call for FDA Openness
Mar 07 | UPI | Two researchers Tuesday urged a change in FDA policies to allow the scientific community access to pharmaceutical manufacturers' clinical trial data in order to help reveal safety issues with new drugs. more
Bio-IT Briefs
Mar 09 | Bio-IT World | FULL STORIES

  • Sigma-Aldrich launches Mission siRNA druggable genome libraries
  • InforSense unveils Customer Hub to empower life scientists and informaticians
  • BlueGnome updates its CytoChip with known copy number variations
  • NIH director launches funding program for innovative new investigators
  • Computer program predicts risk of breast cancer

 
Advertisement
Ads By Google
 
The CHI Network

For reprints and/or copyright permission, please contact RMS, 1808 Colonial Village Lane, Lancaster, PA; (717) 399-1900 ext 100 or via email to [email protected].

 

©2002-2007 Bio-IT World Inc. Privacy Policy | March 14, 2007